426
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
this post was submitted on 23 Jan 2024
426 points (95.7% liked)
Technology
59982 readers
2242 users here now
This is a most excellent place for technology news and articles.
Our Rules
- Follow the lemmy.world rules.
- Only tech related content.
- Be excellent to each another!
- Mod approved content bots can post up to 10 articles per day.
- Threads asking for personal tech support may be deleted.
- Politics threads may be removed.
- No memes allowed as posts, OK to post as comments.
- Only approved bots from the list below, to ask if your bot can be added please contact us.
- Check for duplicates before posting, duplicates may be removed
Approved Bots
founded 2 years ago
MODERATORS
Nobody is buying this and I don't think they are trying very hard to sell it either. Notice that this pricing is only in the U.S. This seems like a ploy to bolster their case for damages and/or royalties in a settlement. Or maybe just part of their patent defense strategy. This company is primarily in medical tech. Even if they aren't so interested in the consumer market, they have to protect their patent or someone in a market they do care about will get away with it too. I would assume it strengthens their case if they can demonstrate material damages in a market they participate in. So quickly unveil a prototype, price it so there's little to no demand, don't bother manufacturing a product nobody wants, win the case, cancel the product.
Hmm, that’s a new theory I haven’t heard. It sounds pretty plausible so I’ll be interested to see if it plays out like that.